What is Cabot Lab?
CABOT LAB operates as a premier molecular laboratory based in Texas, specializing in the delivery of precise and rapid PCR and NGS testing services. The company offers a comprehensive suite of diagnostic panels, including those for COVID-19, sexually transmitted infections, respiratory and urinary tract infections, and women's health. CABOT LAB is committed to leveraging advanced technology and ensuring swift turnaround times to provide healthcare providers with high-quality, personalized support, ultimately aiming to improve patient outcomes through expert diagnostic solutions.
How much funding has Cabot Lab raised?
Cabot Lab has raised a total of $81K across 1 funding round:
Debt
$81K
Debt (2021): $81K with participation from PPP
Key Investors in Cabot Lab
PPP
Public-Private Partnership
What's next for Cabot Lab?
The recent influx of substantial expansion capital positions Cabot Lab for accelerated growth and market penetration. As a company at a significant Series B/C stage, this financing is expected to fuel further development of its testing services, enhance operational capacity, and potentially expand its geographic reach. Strategic investments in technology and personnel will likely be key priorities, enabling Cabot Lab to solidify its standing as a leading provider of molecular diagnostics and capitalize on evolving healthcare demands.
See full Cabot Lab company page
